These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20043391)

  • 1. [New treatment strategies for the management of hypertension].
    Reinhardt A; Linsel-Nitschke P; Schunkert H
    MMW Fortschr Med; 2009 Nov; 151(46):33-6. PubMed ID: 20043391
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treating hypertension only in case of high risk? Evidence-based therapy with cost control].
    Trenkwalder P
    MMW Fortschr Med; 2001 Feb; 143(7):45-6. PubMed ID: 11268751
    [No Abstract]   [Full Text] [Related]  

  • 3. The value of antihypertensive drugs: a perspective on medical innovation.
    Cutler DM; Long G; Berndt ER; Royer J; Fournier AA; Sasser A; Cremieux P
    Health Aff (Millwood); 2007; 26(1):97-110. PubMed ID: 17211019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving practice guidelines with patient-specific recommendations.
    Owens DK
    Ann Intern Med; 2011 May; 154(9):638-9. PubMed ID: 21536940
    [No Abstract]   [Full Text] [Related]  

  • 5. The cost-effectiveness of implementing a new guideline for cardiovascular risk management in primary care in the Netherlands.
    Kok L; Engelfriet P; Jacobs-van der Bruggen MA; Hoogenveen RT; Boshuizen HC; Verschuren MW
    Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):371-6. PubMed ID: 19305351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of the Canadian Hypertension Education Programme in its first decade.
    McAlister FA; Feldman RD; Wyard K; Brant R; Campbell NR;
    Eur Heart J; 2009 Jun; 30(12):1434-9. PubMed ID: 19454575
    [No Abstract]   [Full Text] [Related]  

  • 7. [Recent development of recommendations for the screening and treatment of arterial hypertension].
    Plouin PF; Bobrie G
    Bull Acad Natl Med; 2002; 186(9):1611-21; discussion 1621-3. PubMed ID: 14556577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II inhibition and prevention of atrial fibrillation and stroke.
    Bourassa MG
    J Am Coll Cardiol; 2005 Mar; 45(5):720-1. PubMed ID: 15734616
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treating essential hypertension. Are beta blockers still first choice?].
    Rahn KH
    MMW Fortschr Med; 2007 May; 149(18):43-5. PubMed ID: 17672414
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacotherapy of hypertension. How much can safely be saved?].
    Anlauf M
    MMW Fortschr Med; 2004 Apr; 146(15):57-8. PubMed ID: 15373022
    [No Abstract]   [Full Text] [Related]  

  • 11. Economic evaluation of ASCOT-BPLA: antihypertensive treatment with an amlodipine-based regimen is cost effective compared with an atenolol-based regimen.
    Lindgren P; Buxton M; Kahan T; Poulter NR; Dahlöf B; Sever PS; Wedel H; Jönsson B;
    Heart; 2008 Feb; 94(2):e4. PubMed ID: 17916665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comment on IOWiG report plan. A medical decision may not be replaced].
    Vorstand der Deutschen Hochdruckliga E.V
    MMW Fortschr Med; 2006 May; 148(19):42. PubMed ID: 16736705
    [No Abstract]   [Full Text] [Related]  

  • 13. [Recent intervention studies with antihypertensive drugs and their influence on guidelines].
    Rahn KH
    Med Klin (Munich); 2003 Dec; 98(12):771-5. PubMed ID: 14685679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individualized guidelines: the potential for increasing quality and reducing costs.
    Eddy DM; Adler J; Patterson B; Lucas D; Smith KA; Morris M
    Ann Intern Med; 2011 May; 154(9):627-34. PubMed ID: 21536939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of antihypertensive treatment in patients 80 years of age or older in Switzerland: an analysis of the HYVET study from a Swiss perspective.
    Szucs TD; Waeber B; Tomonaga Y
    J Hum Hypertens; 2010 Feb; 24(2):117-23. PubMed ID: 19536166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of hypertension in the elderly].
    Hohage H; Gerhardt U; Suwelack BM
    Med Klin (Munich); 2003 Sep; 98(9):511-21. PubMed ID: 14551708
    [No Abstract]   [Full Text] [Related]  

  • 17. [Organizational committee shines with incompetence].
    Aumiller J
    MMW Fortschr Med; 2005 Dec; 147(51-52):59-60. PubMed ID: 16402712
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacoeconomic issues in antihypertensive treatment].
    Saito I
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():271-5. PubMed ID: 16981554
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hypertension and stroke: new publications in 2005].
    Schrader J
    MMW Fortschr Med; 2005 Nov; 147(46):40-2, 44. PubMed ID: 16358633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypertension in the elderly].
    Plouin PF; Rossignol P; Bobrie G
    Bull Acad Natl Med; 2006; 190(4-5):793-805; discussion 806, 873-6. PubMed ID: 17195607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.